Tirzepatide

Tirzepatide is a synthetic dual GIP and GLP-1 receptor analog research peptide. It is supplied as a high-purity lyophilized powder for laboratory use only.

The compound is a modified 39-amino-acid incretin analog with a fatty-diacid side chain. Reported specifications commonly include a molecular weight of approximately 4814 g/mol. Identity and purity are confirmed by HPLC and mass spectrometry.

In laboratory and preclinical research, tirzepatide has been investigated for effects on GIP and GLP-1 receptor signaling, including studies related to incretin-pathway activity, glycemic-regulation models, and energy-balance mechanisms in experimental systems. These findings are limited to research settings and do not establish approved medical use.

This material is not approved for human or veterinary use and is not intended for consumption.